Brusatol attenuated proliferation and invasion induced by KRAS in differentiated thyroid cancer through inhibiting Nrf2

被引：0
|
作者：
Z. Gong
L. Xue
A. C. Vlantis
C. A. van Hasselt
J. Y. K. Chan
J. Fang
R. Wang
Y. Yang
D. Li
X. Zeng
M. C. F. Tong
G. G. Chen
机构：
[1] Prince of Wales Hospital,Department of Otorhinolaryngology, Head and Neck Surgery
[2] The Chinese University of Hong Kong,Department of Otolaryngology Head and Neck Surgery
[3] Shenzhen Research Institute,Key Laboratory of Otolaryngology Head and Neck Surgery (Ministry of Education of China)
[4] The Chinese University of Hong Kong,Shenzhen Key Laboratory of ENT
[5] Beijing Tongren Hospital,undefined
[6] Capital Medical University,undefined
[7] Beijing Institute of Otolaryngology,undefined
[8] Institute of ENT and Longgang ENT Hospital,undefined
来源：
Journal of Endocrinological Investigation | 2024年 / 47卷
关键词：
Dedifferentiation; KRAS; Nrf2; Brusatol; Thyroid cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1271 / 1280
页数：9
相关论文
共 50 条
  • [1] Brusatol attenuated proliferation and invasion induced by KRAS in differentiated thyroid cancer through inhibiting Nrf2
    Gong, Z.
    Xue, L.
    Vlantis, A. C.
    van Hasselt, C. A.
    Chan, J. Y. K.
    Fang, J.
    Wang, R.
    Yang, Y.
    Li, D.
    Zeng, X.
    Tong, M. C. F.
    Chen, G. G.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2024, 47 (05) : 1271 - 1280
  • [2] Brusatol, an NRF2 inhibitor for future cancer therapeutic
    Cai, Sabrina J.
    Liu, Yang
    Han, Sue
    Yang, Chunzhang
    CELL AND BIOSCIENCE, 2019, 9 (1):
  • [3] Brusatol, an NRF2 inhibitor for future cancer therapeutic
    Sabrina J. Cai
    Yang Liu
    Sue Han
    Chunzhang Yang
    Cell & Bioscience, 9
  • [4] Propofol induces proliferation and invasion of gallbladder cancer cells through activation of Nrf2
    Zhang, Lingmin
    Wang, Ning
    Zhou, Suna
    Ye, Wenguang
    Jing, Guixia
    Zhang, Mingxin
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2012, 31
  • [5] Propofol induces proliferation and invasion of gallbladder cancer cells through activation of Nrf2
    Lingmin Zhang
    Ning Wang
    Suna Zhou
    Wenguang Ye
    Guixia Jing
    Mingxin Zhang
    Journal of Experimental & Clinical Cancer Research, 31
  • [6] Allicin suppresses the migration and invasion in cervical cancer cells mainly by inhibiting NRF2
    Zhang, Qiumei
    Yang, Dongmei
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 17 (03) : 1523 - 1528
  • [7] Nrf2 in Pancreatic Cancer Chemotherapy Response and the Use of Brusatol as a Chemotherapeutic Agent
    Williams, D.
    Gana, T.
    Sivapalan, L.
    Butler, O.
    Jackson, R.
    Perez-Mancera, P.
    Barrera-Briceno, L.
    Copple, I.
    Cox, T.
    Goldring, C.
    Halloran, C. M.
    Ghaneh, P.
    Palmer, D.
    Strobel, O.
    Greenhalf, W.
    Neoptolemos, J. P.
    Costello, E.
    PANCREAS, 2017, 46 (10) : 1443 - 1443
  • [8] Inhibition of Nrf2 reduced cell motility and proliferation in KRAS mutant lung cancer cells
    Ko, E.
    Kwon, S.
    Lee, J.
    FEBS OPEN BIO, 2019, 9 : 192 - 192
  • [9] The regulation of proliferation and invasion in differentiated thyroid cancer by growth factors
    Hoelting, T
    Duh, QY
    Clark, OH
    Herfarth, C
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 1996, 104 : 29 - 31
  • [10] Triptolide inhibits proliferation and invasion of colorectal cancer cells by blocking Nrf2 expression
    Wang, Hui-feng
    Zhao, Zhi-long
    CHEMICAL BIOLOGY & DRUG DESIGN, 2024, 103 (01)
12345